Attempting to define and refine vasopressin use in septic shock: the VANISH trial.

about

Attempting to define and refine vasopressin use in septic shock: the VANISH trial.

Item

http://www.wikidata.org/entity/Q42330831

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Attempting to define and refine vasopressin use in septic shock: the VANISH trial.

@en

Attempting to define and refine vasopressin use in septic shock: the VANISH trial.

@nl

type

Item

label

Attempting to define and refine vasopressin use in septic shock: the VANISH trial.

@en

Attempting to define and refine vasopressin use in septic shock: the VANISH trial.

@nl

prefLabel

Attempting to define and refine vasopressin use in septic shock: the VANISH trial.

@en

Attempting to define and refine vasopressin use in septic shock: the VANISH trial.

@nl

P1476

Attempting to define and refine vasopressin use in septic shock: the VANISH trial.

@en

P2093

Aviral Roy

http://www.w3.org/2001/XMLSchema#string

Richard Phillip Dellinger

http://www.w3.org/2001/XMLSchema#string

P2860

Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.

The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series.

Vasopressin versus norepinephrine infusion in patients with septic shock.

Endocrine dysfunction in sepsis: a beneficial or deleterious host response?

Bench-to-bedside review: Vasopressin in the management of septic shock

Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis.

Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

P304

501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/ATM.2016.12.11

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28149863

http://www.w3.org/2001/XMLSchema#string

P921

AVP

sepsis

P932

5233516

http://www.w3.org/2001/XMLSchema#string